Carter to lead Fusion Energy Division at Oak Ridge National Laboratory
Systems biologist Paul Abraham uses his fascination with proteins, the molecular machines of nature, to explore new ways to engineer more productive ecosystems and hardier bioenergy crops.
Scientists at Oak Ridge National Laboratory and Ohio State University discovered a new microbial pathway that produces ethylene, providing a potential avenue for biomanufacturing a common component of plastics, adhesives, coolants and other
The Department of Energy has selected Oak Ridge National Laboratory to lead a collaboration charged with developing quantum technologies that will usher in a new era of innovation.
Oak Ridge National Laboratory researchers have designed and additively manufactured a first-of-its-kind aluminum device that enhances the capture of carbon dioxide emitted from fossil fuel plants and other industrial processes.
As CASL ends and transitions to VERA Users Group, ORNL looks at the history of the program and its impact on the nuclear industry.
Scientists at the Department of Energy’s Oak Ridge National Laboratory have a powerful new tool in the quest to produce better plants for biofuels, bioproducts and agriculture.
Pick your poison. It can be deadly for good reasons such as protecting crops from harmful insects or fighting parasite infection as medicine — or for evil as a weapon for bioterrorism. Or, in extremely diluted amounts, it can be used to enhance beauty.
An all-in-one experimental platform developed at Oak Ridge National Laboratory’s Center for Nanophase Materials Sciences accelerates research on promising materials for future technologies.
Combining expertise in physics, applied math and computing, Oak Ridge National Laboratory scientists are expanding the possibilities for simulating electromagnetic fields that underpin phenomena in materials design and telecommunications.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.